Clinical Trial Update: A Study to Investigate LYL845 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

Lyell Immunopharma reports termination of the Phase 1 trial evaluating LYL845 in adults with solid tumors, including melanoma, non-small cell lung cancer, and c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• LYL845

Snippet

Sponsor: Lyell Immunopharma, Inc. | Conditions: Melanoma, Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED